ACON

Aclarion, Inc.

0.1772

Top Statistics
Market Cap 1 M Forward PE -0.2726 Revenue Growth -35.70 %
Current Ratio 1.28 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -0.2120 Enterprise / Revenue 17.80 Price To Sales Trailing12 Months 34.26
Profitability
Profit Margins 0.00 % Operating Margins -10350.57 %
Balance Sheet
Total Cash 1 M Total Cash Per Share 0.1420 Total Debt 777087
Total Debt To Equity 47.32 Current Ratio 1.28 Book Value Per Share -0.8820
All Measures
Short Ratio 77.00 % Message Board Id finmb_108179695 Shares Short Prior Month 261448
Return On Equity -7.14 City Broomfield Uuid e788cafd-f3cb-3638-aec4-1ba7a1daacb1
Previous Close 0.1812 First Trade Date Epoch Utc 1 B Book Value -0.8820
Beta 0.3960 Total Debt 777087 Volume 238110
Last Split Date 1 B Fifty Two Week Low 0.1600 Total Cash Per Share 0.1420
Total Revenue 53947 Shares Short Previous Month Date 1 B Target Median Price 1.15
Max Age 86400 Recommendation Mean 1.50 Sand P52 Week Change 0.3133
Operating Margins -10350.57 % Target Mean Price 1.15 Net Income To Common -5900537
Short Percent Of Float 0.0428 Implied Shares Outstanding 10 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 214360 Average Volume10days 214360
Total Cash 1 M Next Fiscal Year End 1 B Revenue Per Share 0.0150
Held Percent Insiders 0.0977 Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 0.1812 Target Low Price 1.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 0.1815 Open 0.1825
Free Cashflow -3944406 State CO Dividend Yield 0.00 %
Return On Assets -1.15 Time Zone Short Name EST Trailing Eps -2.40
Day Low 0.1772 Address1 8181 Arista Place Shares Outstanding 10 M
Price Hint 4 Target High Price 1.30 Website https://www.aclarion.com
52 Week Change -0.9590 Average Volume 481273 Forward Eps -0.5400
Recommendation Key strong_buy Compensation As Of Epoch Date 1 B Quick Ratio 85.90 %
Last Split Factor 1:16 Regular Market Day High 0.1855 Is_sp_500 False
Profit Margins 0.00 % Debt To Equity 47.32 Fifty Two Week High 7.39
Day High 0.1855 Shares Short 428828 Regular Market Open 0.1825
Industry Key health-information-services Earnings Growth 0.00 % Enterprise To Revenue 17.80
Revenue Growth -35.70 % Shares Percent Shares Out 0.0427 Operating Cashflow -4979390
Currency USD Time Zone Full Name America/New_York Market Cap 1 M
Is_nasdaq_100 False Zip 80021 Quote Type EQUITY
Industry Health Information Services Long Name Aclarion, Inc. Regular Market Day Low 0.1772
Held Percent Institutions 0.0357 Current Price 0.1772 Address2 Suite 100
Enterprise To Ebitda -0.2120 Financial Currency USD Current Ratio 1.28
Gross Margins -51.53 % Industry Disp Health Information Services Number Of Analyst Opinions 2
Country United States Float Shares 7 M Two Hundred Day Average 0.3096
Enterprise Value 960522 Price To Sales Trailing12 Months 34.26 Forward PE -0.2726
Regular Market Volume 238110 Ebitda -4525660 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha
Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States.

It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software.

The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021.

Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.